Characteristics | Samples | Five-year survival (%) | Log-rank (X 2 value) | P value |
---|---|---|---|---|
Gender (male/female) | 77/44 | 35.5/49.5 | 0.527 | 0.468 |
Lauren type | ||||
Intestinal type | 109 | 46.1 | 6.322 | 0.012 |
Diffuse type | 12 | 0 | ||
Type of histology | ||||
1–2 | 75 | 40.5 | 0.000 | 0.990 |
3 | 46 | 40.0 | ||
Lymphatic vessel invasion | ||||
Negative | 54 | 60.6 | 14.199 | 0.000 |
Positive | 67 | 18.3 | ||
Blood vessel invasion | ||||
Negative | 100 | 43.7 | 13.455 | 0.000 |
Positive | 21 | 28.8 | ||
Lymph nodes metastasis | ||||
Negative | 44 | 79.0 | 24.919 | 0.000 |
Positive | 77 | 13.0 | ||
Depth of invasion | ||||
T1 | 18 | 94.1 | 25.835 | 0.000 |
T2 | 31 | 56.0 | ||
T3 | 31 | 36.7 | ||
T4 | 41 | 0 | ||
N stage (UICC) | ||||
N0 | 43 | 78.9 | 34.320 | 0.000 |
N1 | 44 | 22.1 | ||
N2 | 24 | 0 | ||
N3 | 10 | 0 | ||
N stage (JRSGC) | ||||
N0 | 42 | 78.9 | 38.976 | 0.000 |
N1 | 38 | 12.6 | ||
N2 | 31 | 16.4 | ||
N3 | 10 | 0 | ||
MLR | ||||
MLR1 | 43 | 78.9 | 36.575 | 0.000 |
MLR2 | 20 | 32.7 | ||
MLR3 | 58 | 0 |